Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.07 +15.80%

+$0.46 today

Market cap
$98.28M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 3.54M

Average 1.15M

QTRX Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Quanterix CorporationNASDAQ: QTRX

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue rises 66.9% from a year ago

Deferred revenue stood at $15.19M at the end of Q1 FY2026, up 66.9% from a year earlier and down 26.7% from the prior quarter. Over 3 fiscal years it compounded at +33.8% a year.

Context

  • Deferred revenue amounted to 4.1% of total assets at the end of Q1 FY2026, up 1.8 pp from a year earlier.
  • Deferred revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +66.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.19M-26.7% QoQ
Last fiscal yearDec 2025
$20.73M+134.8% YoY
Year agoMar 2025
$9.1M+66.9% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+66.9%——
1 year+134.8%——
3-year CAGR+33.8%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
20.73M USD
Year-over-year change
+134.8%
4-year CAGR
+34.4%

Deferred Revenue vs competitors

How QTRX compares with its peers on the latest reported figures

  • QTRX's Mar 2026 deferred revenue of $15.19M is the highest of the 11 companies compared; the peer median is $267K.
  • Its year-over-year change of +66.9% is the 2nd highest of 7, against a peer median of -3.3%.
  • Deferred revenue amounts to 4.1% of total assets for QTRX, versus a peer median of 0.2%.
QTRX Competitors Peer median
Deferred Revenue for QTRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
QTRXQuanterix CorporationMar 2026$15.19M +66.9%+33.8%4.1%
OMOutset Medical, Inc.Mar 2026$12.64M -4.2%+16.8%5.1%
MASS908 Devices Inc.Mar 2026$9.47M -2.4%+5.9%5.1%
VMDViemed Healthcare, Inc.Mar 2026$7.48M +10.1%+17.6%3.8%
INGNInogen, Inc.Mar 2026$5.09M -20.6%-14.7%1.8%
NNOXNano-X Imaging Ltd.Dec 2025$534K +281.4%+43.2%0.3%
SGHTSight Sciences, Inc.Mar 2026$0 ——0.0%
SENSSenseonics Holdings, Inc.Mar 2026$0 ——0.0%
IMRXImmuneering CorporationMar 2026$0 ——0.0%
CVRXCVRx, Inc.Mar 2026$0 ——0.0%
SNWVSANUWAVE Health, Inc.Mar 2026$0 -100.0%+86.3%0.0%
Peer median (excluding QTRX) $267K-3.3%+17.2%0.2%

Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents396.47M338.74M174.42M56.71M29.84M
Short-term Investments00146.9M232.41M88.39M
Net Receivables23.79M19.02M25.41M32.14M29.97M
Inventory22.19M16.96M26.12M32.78M54.76M
Other Current Assets6.51M6.8M9.23M9.56M9.29M
Total Current Assets448.96M381.52M382.1M363.59M212.26M
Property, Plant & Equipment (Net)29.45M41.03M36.18M33.49M40.34M
Goodwill9.63M00026.38M
Intangible Assets10.53M7.52M6.03M4.03M131.79M
Long-term Investments2.58M2.6M000
Tax Assets4.99M7.77M000
Other Non-current Assets378K(6.86M)4.26M5.42M8.01M
Total Non-current Assets57.56M52.06M46.47M42.94M206.51M
Total Assets506.51M433.58M428.57M406.53M418.77M
Account Payables9.21M3.84M5.05M6.95M13.57M
Short-term Debt00000
Tax Payables00822K1.02M0
Deferred Revenue6.36M8.64M9.47M8.83M20.73M
Other Current Liabilities13.49M11.04M14.17M12.62M21.85M
Total Current Liabilities36.98M31.35M38.98M42.01M74.76M
Long-term Debt00000
Deferred Tax Liabilities7.02M9.24M1.18M800K8.1M
Deferred Revenue (Non-current)1.1M1.42M1.23M1.07M5.83M
Other Non-current Liabilities0(7.77M)005.02M
Total Non-current Liabilities28.59M44.3M39.63M34.49M48.27M
Total Liabilities65.56M75.65M78.61M76.5M123.04M
Common Stock37K37K38K39K47K
Retained Earnings(305.46M)(403.2M)(431.55M)(470.08M)(577.23M)
Accumulated OCI441K(2.54M)(1.67M)(3.08M)(723K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity440.95M357.93M349.96M330.04M295.73M
Total Debt21.89M44.1M41.46M37.37M37.24M
Net Debt(374.57M)(294.64M)(132.96M)(19.34M)7.4M

Quanterix Corporation

NASDAQ:QTRX

Intrinsic Alpha fair value

Locked

Current Price

$2.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.